Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Huang

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical Oral Implants Research|June 29, 2023
Surgical peri-implantitis treatment with and without guided bone regeneration. A randomized controlled trialLisa J A Heitz-Mayfield, Fritz Heitz, Bernard Koong, et al.
Rapid Communications in Mass Spectrometry : RCM|January 6, 2010
Investigation of collision-induced dissociations involving odd-electron ion formation under positive electrospray ionization conditions using accurate massGuifen Xu, Tom Huang, Jennifer Zhang, et al.
Korean Circulation Journal|May 19, 2020
The Long Journey of Cardiac Lymphoma Follow-upJoseph C Lee, Yi Tung Tom Huang, Yu Ting Huang, et al.
Advanced Healthcare Materials|January 22, 2025
Universal Hydrogel Carrier Enhances Bone Graft Success: Preclinical and Clinical EvaluationDax Calder, Farshad Oveissi, Simin Maleknia, et al.
Bioanalysis|September 6, 2012
Application of DBS sampling in combination with LC-MS/MS for pharmacokinetic evaluation of a compound with species-specific blood-to-plasma partitioningGuifen Xu, Jiyun S Chen, Ruta Phadnis, et al.
Cancer Research Communications|March 27, 2023
CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and ChemotherapyAnthony Cao, Jiaqing Yi, Xinyan Tang, et al.
Cancer Research Communications|September 4, 2023
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK InhibitorShruti Lal, Neil E Bhola, Bee-Chun Sun, et al.
Journal of Medicinal Chemistry|July 6, 2019
Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633)Xiaohui Du, John Eksterowicz, Haiying Zhou, et al.
Journal of Medicinal Chemistry|August 10, 2018
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101)Yosup Rew, Xiaohui Du, John Eksterowicz, et al.
Cancer Research Communications|March 16, 2023
ZL-1211 Exhibits Robust Antitumor Activity by Enhancing ADCC and Activating NK Cell-mediated Inflammation in CLDN18.2-High and -Low Expressing Gastric Cancer ModelsHiroyasu Konno, Tracey Lin, Renyi Wu, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Oral Implants Research|June 29, 2023
Surgical peri-implantitis treatment with and without guided bone regeneration. A randomized controlled trialLisa J A Heitz-Mayfield, Fritz Heitz, Bernard Koong, et al.
Rapid Communications in Mass Spectrometry : RCM|January 6, 2010
Investigation of collision-induced dissociations involving odd-electron ion formation under positive electrospray ionization conditions using accurate massGuifen Xu, Tom Huang, Jennifer Zhang, et al.
Korean Circulation Journal|May 19, 2020
The Long Journey of Cardiac Lymphoma Follow-upJoseph C Lee, Yi Tung Tom Huang, Yu Ting Huang, et al.
Advanced Healthcare Materials|January 22, 2025
Universal Hydrogel Carrier Enhances Bone Graft Success: Preclinical and Clinical EvaluationDax Calder, Farshad Oveissi, Simin Maleknia, et al.
Bioanalysis|September 6, 2012
Application of DBS sampling in combination with LC-MS/MS for pharmacokinetic evaluation of a compound with species-specific blood-to-plasma partitioningGuifen Xu, Jiyun S Chen, Ruta Phadnis, et al.
Cancer Research Communications|March 27, 2023
CD47-blocking Antibody ZL-1201 Promotes Tumor-associated Macrophage Phagocytic Activity and Enhances the Efficacy of the Therapeutic Antibodies and ChemotherapyAnthony Cao, Jiaqing Yi, Xinyan Tang, et al.
Cancer Research Communications|September 4, 2023
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK InhibitorShruti Lal, Neil E Bhola, Bee-Chun Sun, et al.
Journal of Medicinal Chemistry|July 6, 2019
Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633)Xiaohui Du, John Eksterowicz, Haiying Zhou, et al.
Journal of Medicinal Chemistry|August 10, 2018
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101)Yosup Rew, Xiaohui Du, John Eksterowicz, et al.
Cancer Research Communications|March 16, 2023
ZL-1211 Exhibits Robust Antitumor Activity by Enhancing ADCC and Activating NK Cell-mediated Inflammation in CLDN18.2-High and -Low Expressing Gastric Cancer ModelsHiroyasu Konno, Tracey Lin, Renyi Wu, et al.
Pageof 3